Left atrial appendage thrombus in patients referred to electrical cardioversion for typical atrial flutter

Łukasz Turek; Marcin Sadowski; Agnieszka Janion-Sadowska; Jacek Kurzawski; Andrzej Jaroszyński

doi:10.5114/ms.2022.117672

eISSN: 2300-6722
ISSN: 1899-1874

Medical Studies/Studia Medyczne

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2022
vol. 38

Send email

Copy url:

abstract:

Original paper

Left atrial appendage thrombus in patients referred to electrical cardioversion for typical atrial flutter

Łukasz Turek

¹

,

Marcin Sadowski

¹

,

Agnieszka Janion-Sadowska

¹

,

Jacek Kurzawski

¹

,

Andrzej Jaroszyński

¹

Institute of Medical Sciences, Collegium Medicum, Jan Kochanowski University, Kielce, Poland Head of the Institute: Beata Kręcisz MD, PhD, Prof. JKU

Medical Studies/Studia Medyczne 2022; 38 (2): 132–139

DOI: https://doi.org/10.5114/ms.2022.117672

Online publish date: 2022/06/30

View full text Get citation

PlumX metrics:

Introduction
Patients with atrial flutter (AFL) are at risk of stroke; however, the stratification of stroke risk is difficult. It remains unknown whether left atrial appendage thrombus (LAAT) in AFL patients on chronic oral anticoagulation (OAC) contributes significantly to that risk.

Aim of the research
To assess the prevalence and predictors of LAAT, and its role in the prediction of mortality, stroke, and systemic thromboembolic events among consecutive AFL patients on OAC admitted for electrical cardioversion.

Material and methods
This was a prospective, single-centre cohort study. The participants underwent transoesophageal echocardiography before electrical cardioversion. A total of 69 patients were enrolled. The primary outcome was the presence of LAAT. All participants were followed up for 12 months to evaluate the incidence of systemic thromboembolic events, stroke, and death.

Results
Despite uninterrupted OAC, irrespective of the anticoagulant agent type, LAAT was present in 10.1% of patients referred for cardioversion due to typical AFL of > 48-hour duration. The significant predictor of LAAT was prior stroke/transient ischaemic attack/thromboembolic event (OR = 14.75; 95% CI: 2.17–108.33). No deaths, strokes, or systemic thromboembolic events occurred during the follow-up period.

Conclusions
The predictive role of LAAT in relation to mortality, stroke, and systemic thromboembolic events among patients with AFL and chronic oral anticoagulation remains unclear.

keywords:

Left atrial appendage thrombus in patients referred to electrical cardioversion for typical atrial flutter

Łukasz Turek 1 , Marcin Sadowski 1 , Agnieszka Janion-Sadowska 1 , Jacek Kurzawski 1 , Andrzej Jaroszyński 1

anticoagulation, atrial flutter, cardioversion, left atrial appendage, thrombus

Łukasz Turek

¹

,

Marcin Sadowski

¹

,

Agnieszka Janion-Sadowska

¹

,

Jacek Kurzawski

¹

,

Andrzej Jaroszyński

¹